BMS-986368
DrugSpecified dose on specified days
NCT Number: NCT07700329
The purpose of the study is to evaluate the drug levels, safety and tolerability of BMS-986368 in healthy Chinese participants
Trial opening soon.
Get Notified18 year–55 year
All sexes
Interventional
Phase 1
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Specified dose on specified days
Specified dose of specified days
Time frame: Up to approximately Day 17
Time frame: Up to approximately Day 17
Time frame: Up to approximately Day 17
Time frame: Up to approximately Day 44
Time frame: Up to approximately Day 44
Time frame: Up to approximately Day 17
Time frame: Up to approximately Day 17
Time frame: Up to approximately Day 17
Time frame: Up to approximately Day 17
Time frame: Up to approximately Day 17
Contact information is provided by the study sponsor or research team.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
First line of the email MUST contain NCT # and Site #.
CONTACT
Celgene
Industry
A Phase 1, Double-Blinded, Randomized, Placebo-Controlled, Two Parallel Cohort Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07504601
Healthy Volunteers, Neurologic Manifestations
Bethesda, Maryland, United States
View Trial DetailsNCT06868914
Chemically-Induced Disorders, Healthy Volunteers
Baltimore, Maryland, United States
View Trial DetailsNCT07719218
Healthy Volunteers, Interstitial Lung Disease (ILD)
View Trial DetailsNCT07709741
Basal Ganglia Diseases, Brain Diseases
Minneapolis, Minnesota, United States
View Trial Details